GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology By Reuters
By Blake Brittain(Reuters) -GlaxoSmithKline sued Pfizer (NYSE:) and BioNTech (NASDAQ:) in Delaware federal court on Thursday, accusing them of infringing ...
By Blake Brittain(Reuters) -GlaxoSmithKline sued Pfizer (NYSE:) and BioNTech (NASDAQ:) in Delaware federal court on Thursday, accusing them of infringing ...
© Reuters. On Wednesday, JPMorgan maintained a Neutral rating for shares of BioNTech (NASDAQ:), a biotechnology company specializing in immunotherapies. ...
Personalisierte mRNA-Krebsimpfstoffe noch vor 2030! Biontech (BNTX) – ISIN – US09075V1026 Biontech-Aktie mit Bottom-Fishing-Setup! Rückblick Um die Biontech-Aktie ist es ...
Even by the normal standards of investor-state dispute settlements (ISDS), Pfizer and BioNtech’s lawsuit against the government of Poland for ...
© Reuters. A compagny logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron/File Photo ...
© Reuters. FILE PHOTO: The logo of BioNTech is seen in Marburg, Germany, February 2, 2023. REUTERS/Fabian Bimmer By Ludwig ...
© Reuters BioNTech SE (BNTX) named catalyst driven idea at Morgan Stanley ahead of PCV early-stage data By Sam Boughedda ...